Best Practice & Research Clinical Endocrinology & Metabolism
Volume 21, Issue 4 , Pages 621-640, December 2007

Inhibition of the protein tyrosine phosphatase PTP1B: potential therapy for obesity, insulin resistance and type-2 diabetes mellitus

  • Shlomit Koren, MD (Research Fellow, Internal Medicine and Endocrinology and Metabolism, Department of Medicine and Banting and Best Diabetes Center, University of Toronto)
  • I. George Fantus, MD, FRCP(C) (Professor, Department of Medicine and Physiology and Director, Division of Endocrinology and Metabolism, University of Toronto)

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: 416 586 8665; Fax: 416 361 2657.

Department of Medicine, Mount Sinai Hospital, University Health Network, University of Toronto, Lebovic Building, 60 Murray Street, 5th Floor, Room 5028, Toronto, Ontario M5T 3L9, Canada

Department of Physiology, and The Banting and Best Diabetes Centre, Toronto General Research Institute, University Health Network, University of Toronto, Toronto, Ontario, Canada

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1521-690X(07)00081-4

doi:10.1016/j.beem.2007.08.004

Best Practice & Research Clinical Endocrinology & Metabolism
Volume 21, Issue 4 , Pages 621-640, December 2007

Article Tools

* Image Usage & Resolution